Chronic myeloid leukemia (CML) is characterized by the presence of t(9;22)(q34;q11.2), which generates the oncogenic tyrosine kinase BCR::ABL1 fusion gene. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.